APA citiranje

Sapir, T., Shifteh, D., Pahmer, M., Goel, S., & Maitra, R. (2020). Protein Arginine Methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K Pathways: A Case for PRMT5 Inhibition and Combination Therapies in Cancer. Mol Cancer Res.

Citação norma Chicago

Sapir, Tzuriel, David Shifteh, Moshe Pahmer, Sanjay Goel, and Radhashree Maitra. "Protein Arginine Methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K Pathways: A Case for PRMT5 Inhibition and Combination Therapies in Cancer." Mol Cancer Res 2020.

MLA citiranje

Sapir, Tzuriel, et al. "Protein Arginine Methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K Pathways: A Case for PRMT5 Inhibition and Combination Therapies in Cancer." Mol Cancer Res 2020.